NDUFAF6 and breast carcinoma: This discovery provides additional evidence supporting the hypothesis of NDUFAF6 as a therapeutic target or predictive biomarker and offers new theoretical foundations and practical guidance for the diagnosis, treatment, and prognosis assessment of breast cancer.